A comparative study of the effects of intramuscular administration of gonadorelin, mating and intrauterine infusion of either raw seminal plasma or seminal plasma purified β-NGF on luteal development in llamas.

Abstract

The aim of this study was to compare the effect of the intramuscular administration of 50μg of gonadorelin acetate versus natural mating, intrauterine infusion (i.u.) of a physiological relevant dose of either raw llama seminal plasma (SP) or purified beta-nerve growth factor from seminal origin (spβ-NGF) on ovulation rate and corpus luteum (CL) development and function in llamas. Females with a follicle (≥8mm) were assigned to groups: (i) i.m. administration of 50μg of gonadorelin acetate (GnRH; positive control; n=4); (ii) single mating (mating; n=6); (iii) i.u. infusion of 4ml of llama SP (SP; n=4); or (iv) i.u. infusion of 10mg of spβ-NGF contained in 4ml of PBS (phosphate-buffered saline) (spβ-NGF; n=6). Ovaries were examined by power Doppler ultrasonography at 0, 1, 3, 6, 12 and 24hr after treatment to determine preovulatory follicle vascularization area (VA), and additionally every 12hr until Day 2 (Day of treatment=Day 0) to determine ovulation. Afterwards, ovaries were examined every other day until Day 8 to evaluate CL diameter and VA. Blood samples were collected on Days 0, 2, 4, 6 and 8 to determine plasma progesterone (P4) concentration. Ovulation rate did not differ (p=.7) among groups, but treatment affected (p<.0001) preovulatory follicle VA. Neither treatment administration nor treatment by time interaction affected (p≥.4) CL diameter, VA and plasma P4 concentration. Mating tended (p=.08) to increase CL VA when compared to the seminal plasma group by Day 8. Intrauterine administration of seminal plasma or spβ-NGF does not increase CL size and function when compared to i.m. GnRH treatment, suggesting that the administration route of spβ-NGF influences its luteotrophic effect in llamas.